A novel cancer therapy using a Mössbauer-isotope compound

Area of Science:

• Nuclear physics
• Molecular biology
• Radiotherapy

Background:

• Conventional radiotherapy requires high doses of ionizing radiation.
• DNA double-strand breaks are the primary lethal damage, but are inefficiently produced by conventional methods.
• Auger electrons, generated by specific isotopes, can produce DNA double-strand breaks more efficiently due to their localized energy deposition.

Purpose of the Study:

• To investigate the potential of 57Fe(III)-bleomycin combined with resonant Mössbauer gamma irradiation for cancer treatment.
• To evaluate the efficacy of this approach at significantly reduced radiation doses compared to conventional radiotherapy.

Main Methods:

• Administration of 57Fe(III)-bleomycin to malignant cells in vitro and in vivo.
• Irradiation of cells with resonant Mössbauer gamma rays (14.4 keV).
• Assessment of cell ablation and comparison of required radiation doses.

Main Results:

• 57Fe(III)-bleomycin and gamma irradiation effectively ablated malignant cells.
• The treatment achieved cell ablation with extremely low radiation doses (approximately 10(-5) Gy).
• This dose is over 100,000 times lower than the ~5 Gy typically required for conventional radiotherapy.

Conclusions:

• The combination of 57Fe(III)-bleomycin and resonant gamma irradiation represents a highly efficient method for cancer cell ablation.
• This Auger cascade-inducing therapy offers a promising strategy for minimizing radiation exposure and side effects in cancer treatment.